Description:
INF 195 is a potent and selective NLRP3 inflammasome inhibitor that has shown significant promise in preclinical studies for its ability to inhibit NLRP3-driven inflammatory responses, including macrophage pyroptosis and IL-1β release. By targeting the NLRP3 inflammasome, INF 195 has demonstrated therapeutic potential in conditions involving excessive inflammation, such as myocardial ischemia/reperfusion injury (IRI).
Handling:
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months.
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance,
we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one
month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at
least 1 hour.